IQVIA awarded FDA contract to expand biologic safety monitoring

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/digitalgenetics)
(Image: iStock/digitalgenetics)

Related tags: Contract

IQVIA has been contracted to expand the safety and efficacy monitoring of biologic products as part of a novel alliance with the US Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER).

IQVIA was selected and awarded two contracts in September 2017 after an open, competitive contracting process, explained Lorrie McNeill, director, Office of Communication, Outreach and Development, FDA CBER.

As part of the agreement, IQVIA — formerly QuintilesIMS​ — will monitor and assist in the evaluation of safety and effectiveness of CBER-regulated vaccines, blood products, and other biologics.

The agreement also marks the launch of CBER’s Biologics Effectiveness and Safety (BEST) Initiative, a component of the Sentinel Initiative, which was launched in May 2008. The Sentinel is the FDA’s national electronic system for monitoring the safety of FDA-regulated medical products.

The BEST Initiative “continues CBER’s public health efforts to develop new active postmarket risk identification and analysis systems in Sentinel to better address surveillance and epidemiological study needs unique to regulated biologic products​,” McNeill told us.

To further support the collaboration, IQVIA has teamed up with the Observational Health Data Science and Informatics (OHDSI​) initiative and its established international network of researchers and observational health databases.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Related suppliers

Follow us

Products

View more

Webinars